Nanobiotix (NBTX) Short term Debt (2019 - 2025)
Historic Short term Debt for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $5.4 million.
- Nanobiotix's Short term Debt fell 45.71% to $5.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.4 million, marking a year-over-year decrease of 45.71%. This contributed to the annual value of $5.3 million for FY2024, which is 189.52% down from last year.
- Nanobiotix's Short term Debt amounted to $5.4 million in Q2 2025, which was down 45.71% from $5.3 million recorded in Q4 2024.
- In the past 5 years, Nanobiotix's Short term Debt registered a high of $10.9 million during Q2 2023, and its lowest value of $4.7 million during Q4 2022.
- For the 5-year period, Nanobiotix's Short term Debt averaged around $6.8 million, with its median value being $5.4 million (2024).
- As far as peak fluctuations go, Nanobiotix's Short term Debt soared by 1986.16% in 2022, and later plummeted by 5041.38% in 2024.
- Over the past 5 years, Nanobiotix's Short term Debt (Quarter) stood at $8.1 million in 2021, then plummeted by 42.6% to $4.7 million in 2022, then rose by 16.14% to $5.4 million in 2023, then decreased by 2.62% to $5.3 million in 2024, then increased by 1.86% to $5.4 million in 2025.
- Its Short term Debt stands at $5.4 million for Q2 2025, versus $5.3 million for Q4 2024 and $5.4 million for Q2 2024.